Portable exhaled breath condensate metabolomics for daily monitoring of adolescent asthma.
Portable methods for measurement and quantification of biological analytes have tremendous promise to advance non-invasive personal health monitoring. Exhaled breath metabolomics shares this promise and has been gaining popularity as a non-invasive technique amenable to a vast range of medical uses. &amp;#13; &amp;#13; This work compares breath metabolite abundances in six healthy control subjects and five asthmatic subjects. Exhaled breath condensate (EBC) samples were collected with a novel miniaturized sampler. This device enables breath sample collection in multiple environments, including intensive care units, outpatient clinics, workplaces, and at home. A total of 293 breath samples were collected and analysed longitudinally, including about 28 samples per subject. EBC was analysed with liquid chromatography-mass spectrometry (LC-MS) to define specific metabolite differences between subjects. Untargeted and targeted metabolomic analyses were performed simultaneously, but with separate data analysis procedures. &amp;#13; &amp;#13; Individual differences among subjects were found longitudinally. When presented by health condition, group differences were enhanced with a clear separation between subjects belonging to either the control or asthmatic group. Unexpectedly, targeted compounds consistently had lower intensities in asthmatics. There is a distinct pattern of a day/night cycle with elevations of peak area values in evening samples. These differences were presented mainly in asthmatic subjects, which can be explained by asthma being a representation of exaggerated amplitudes compared to healthy circadian patterns.&amp;#13; &amp;#13; Untargeted and targeted analysis of EBC using this device allows the discovery of novel endogenous metabolic signals in a biological sample and the daily monitoring of selected metabolites related to diseases and medical conditions.&amp;#13.